These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25954917)

  • 21. On the armament and appearances of human myeloid-derived suppressor cells.
    Poschke I; Kiessling R
    Clin Immunol; 2012 Sep; 144(3):250-68. PubMed ID: 22858650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients.
    Jiang J; Guo W; Liang X
    Hum Immunol; 2014 Nov; 75(11):1128-37. PubMed ID: 25305034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptors, triggering receptor expressed on myeloid cells family members and receptor for advanced glycation end-products in allergic airway inflammation.
    Hall SC; Agrawal DK
    Expert Rev Respir Med; 2016 Feb; 10(2):171-84. PubMed ID: 26678062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Balancing the innate immune system in tumor development.
    Hagerling C; Casbon AJ; Werb Z
    Trends Cell Biol; 2015 Apr; 25(4):214-20. PubMed ID: 25444276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The multi-faceted roles of prostaglandin E2 in cancer-infiltrating mononuclear phagocyte biology.
    Sha W; Brüne B; Weigert A
    Immunobiology; 2012 Dec; 217(12):1225-32. PubMed ID: 22727331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?
    Roe K; Gibot S; Verma S
    Front Microbiol; 2014; 5():627. PubMed ID: 25505454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble Triggering Receptor Expressed on Myeloid Cells-1: Diagnosis or Prognosis?
    Lemarié J; Gibot S
    Crit Care Clin; 2020 Jan; 36(1):41-54. PubMed ID: 31733681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of triggering receptor expressed on myeloid cells-1 protects monocyte from apoptosis through regulation of myeloid cell leukemia-1.
    Cai M; Chen Q; Chen C; Liu X; Hou J; Zeng C; Shu Q; Fang X
    Anesthesiology; 2013 May; 118(5):1140-9. PubMed ID: 23364598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloid-Derived Suppressor Cells and Proinflammatory Cytokines as Targets for Cancer Therapy.
    Atretkhany KN; Drutskaya MS
    Biochemistry (Mosc); 2016 Nov; 81(11):1274-1283. PubMed ID: 27914453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the triggering receptor expressed on myeloid cells-1 (TREM-1) in non-bacterial infections.
    de Oliveira Matos A; Dos Santos Dantas PH; Figueira Marques Silva-Sales M; Sales-Campos H
    Crit Rev Microbiol; 2020 May; 46(3):237-252. PubMed ID: 32326783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives.
    Tammaro A; Derive M; Gibot S; Leemans JC; Florquin S; Dessing MC
    Pharmacol Ther; 2017 Sep; 177():81-95. PubMed ID: 28245991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Danger-associated molecular patterns and inflammatory bowel disease: is there a connection?
    Mueller C
    Dig Dis; 2012; 30 Suppl 3():40-6. PubMed ID: 23295691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer.
    Ohki S; Shibata M; Gonda K; Machida T; Shimura T; Nakamura I; Ohtake T; Koyama Y; Suzuki S; Ohto H; Takenoshita S
    Oncol Rep; 2012 Aug; 28(2):453-8. PubMed ID: 22614133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?
    Apte RN; Voronov E
    Immunol Rev; 2008 Apr; 222():222-41. PubMed ID: 18364005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of the TREM-1/DAP12 pathway in the innate immune responses to Porphyromonas gingivalis.
    Bostanci N; Thurnheer T; Belibasakis GN
    Mol Immunol; 2011 Oct; 49(1-2):387-94. PubMed ID: 21967868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
    Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
    Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory receptors on myeloid cells: new targets for therapy?
    Munitz A
    Pharmacol Ther; 2010 Jan; 125(1):128-37. PubMed ID: 19913051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triggering Receptor Expressed on Myeloid Cells in Cutaneous Melanoma.
    Nguyen AH; Koenck C; Quirk SK; Lim VM; Mitkov MV; Trowbridge RM; Hunter WJ; Agrawal DK
    Clin Transl Sci; 2015 Oct; 8(5):441-4. PubMed ID: 26184544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid-derived suppressor cell role in tumor-related inflammation.
    Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V
    Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance.
    Chen Q; Zhang K; Jin Y; Zhu T; Cheng B; Shu Q; Fang X
    Am J Respir Crit Care Med; 2013 Jul; 188(2):201-12. PubMed ID: 23721075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.